[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100603310":3},{"organization":4,"armGroups":7,"interventions":7,"overallOfficials":8,"centralContacts":16,"locations":22,"responsibleParty":45,"collaborators":47,"id":50,"slug":7,"hasResults":51,"nctId":52,"briefTitle":53,"officialTitle":54,"acronym":7,"eligibilityCriteria":55,"healthyVolunteers":51,"sex":56,"minAge":57,"maxAge":7,"enrollmentInfo":58,"targetDuration":7,"studyType":61,"phases":7,"briefSummary":62,"conditions":63,"keywords":67,"overallStatus":71,"whyStopped":7,"lastUpdateSubmitDate":72,"lastUpdatePostDateStruct":73,"startDateStruct":76,"completionDateStruct":78,"leadSponsor":80,"locationsCount":81},{"fullName":5,"class":6},"University College, London","OTHER",null,[9,13],{"name":10,"affiliation":11,"role":12},"John R Hurst, PhD FRCP","University College London Hospitals","PRINCIPAL_INVESTIGATOR",{"name":14,"affiliation":15,"role":12},"Renata G Mendes, DFisio","Federal University of Sao Carlos (UFScar), Brasil",[17],{"name":18,"role":19,"phone":20,"phoneExt":7,"email":21},"Viviane Castello","CONTACT","(+5516) 99992 4777","vivianecastello@ufscar.br",[23,37],{"facility":24,"status":7,"city":25,"state":26,"zip":7,"country":27,"countryCode":28,"cosmosGeoPoint":29,"geoPoint":34,"contacts":35},"Multiple primary care sites","São Carlos","São Paulo","Brazil","BR",{"type":30,"coordinates":31},"Point",[32,33],-47.89083,-22.0175,{"lat":33,"lon":32},[36],{"name":18,"role":19,"phone":20,"phoneExt":7,"email":21},{"facility":24,"status":7,"city":26,"state":26,"zip":7,"country":27,"countryCode":28,"cosmosGeoPoint":38,"geoPoint":42,"contacts":43},{"type":30,"coordinates":39},[40,41],-46.63611,-23.5475,{"lat":41,"lon":40},[44],{"name":18,"role":19,"phone":20,"phoneExt":7,"email":21},{"type":46,"investigatorFullName":7,"investigatorTitle":7,"investigatorAffiliation":7,"oldNameTitle":7,"oldOrganization":7},"SPONSOR",[48],{"name":49,"class":6},"Universidade Federal de Sao Carlos","100603310",false,"NCT07134855","Mitigating Chronic Respiratory Disease Through the Lens of Multimorbidity (MARES3)","Evaluating Care Pathways for Chronic Respiratory Diseases in Brazil","Inclusion Criteria:\n\nParticipated in MARES1 and MARES2, which recruited people with non-communicable diseases attending primary healthcare services in Brazil, identified as being at high-risk for, or confirmed as having chronic respiratory diseases.\n\nExclusion Criteria:\n\n* No consent to take part in MARES3.","ALL","30 Years",{"count":59,"type":60},473,"ESTIMATED","OBSERVATIONAL","The investigators aim to investigate how individuals attending primary healthcare (PHC) services in Brazil for treatment of non-communicable diseases (NCDs), identified there as having abnormal spirometry or as being at high risk for lung health problems (such as asthma and chronic obstructive pulmonary disease-COPD, collectively referred to as chronic respiratory disease (CRDs)) using the COLA-6 questionnaire, are able to access diagnostic testing and treatment.\n\nThe investigators will re-assess people diagnosed with abnormal spirometry in the MARES1 study (NCT07050823) or identified as being at high-risk for CRDs in the MARES2 study (NCT07093021). The estimated sample size is 309 from MARES1 and 164 from MARES2 for a total sample size of 473.\n\nQualitative interviews will be conducted with a diverse subsample of 30 participants to explore their experience accessing CRD diagnosis and treatment, including barriers and facilitators, while all participants will undergo basic data collection and spirometry.",[64,65,66],"Chronic Obstructive Pulmonary Disease (COPD)","Asthma","Preserved Ratio Impaired Spirometry (PRISM)",[68,69,70],"chronic obstructive pulmonary disease","asthma","multi-morbidity","NOT_YET_RECRUITING","2025-08-14",{"date":74,"type":75},"2025-08-21","ACTUAL",{"date":77,"type":60},"2025-09-01",{"date":79,"type":60},"2028-07-31",{"name":5,"class":6},2]